Decoding Immune Mechanisms in BCG-unresponsive Non-muscle Invasive Bladder Cancer

Non-muscle-invasive bladder cancer (NMIBC) accounts for roughly 75% of all bladder cancer cases. For patients with intermediate- and high-risk disease, intravesical Bacillus Calmette-Guérin (BCG) remains the standard treatment, yet it fails in up to 40% of cases. While radical cystectomy is the most...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Mohamad Abou Chakra, Igor Duquesne, Michael A O’Donnell
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	IMR Press 2026-04-01
Edice:	Frontiers in Bioscience-Landmark
Témata:	non muscle invasive bladder cancer urinary bladder neoplasms bacillus calmette-guérin bcg unresponsive disease tumor microenvironment immune evasion immunotherapy
On-line přístup:	https://www.imrpress.com/journal/FBL/31/5/10.31083/FBL47606
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!